BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19759088)

  • 1. Persistent diarrhoea in a young woman.
    Ramnarace R; Ricketts J; Dalton H
    BMJ; 2009 Sep; 339():b3369. PubMed ID: 19759088
    [No Abstract]   [Full Text] [Related]  

  • 2. Investigating young adults with chronic diarrhoea in primary care.
    Chapman TP; Chen LY; Leaver L
    BMJ; 2015 Feb; 350():h573. PubMed ID: 25716699
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of bismuth tripotassium dicitrate (De-Nol), a promising line of pathogenetic therapy for irritated bowel syndrome with diarrhea].
    Iakovenko EP; Agafonova NA; Pokhal'skaia OIu; Kolganova AV; Nazarbekova RS; Ivanov AN; Davletshina IV; Popova EV; Prianishnikova AS; Ovchinnikova NI; Iakovenko AV; Aldiiarova MA; D'iachkoava AV; Gioeva IZ
    Klin Med (Mosk); 2008; 86(10):47-52. PubMed ID: 19069460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ask the doctor. I have chronic diarrhea because of irritable bowel syndrome (IBS). Should I take probiotics?
    Robb-Nicholson C
    Harv Womens Health Watch; 2013 Mar; 20(7):2. PubMed ID: 23862208
    [No Abstract]   [Full Text] [Related]  

  • 5. Is diarrhea-predominant irritable bowel syndrome a low-grade gut inflammatory disorder?
    Ghoshal UC
    Trop Gastroenterol; 2012; 33(4):239-41. PubMed ID: 23923348
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of irritable bowel syndrome].
    Németh AM
    Orv Hetil; 2004 Jul; 145(30):1573-5. PubMed ID: 15382621
    [No Abstract]   [Full Text] [Related]  

  • 7. Alosetron for severe diarrhea-predominant irritable bowel syndrome: improving patient outcomes.
    Bleser S
    Curr Med Res Opin; 2011 Mar; 27(3):503-12. PubMed ID: 21208139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic diarrhoea].
    Spoto S
    Clin Ter; 2003; 154(5):369-73. PubMed ID: 14994928
    [No Abstract]   [Full Text] [Related]  

  • 9. Evidence-based medicine in practice: applying intention-to-treat analysis and perprotocol analysis.
    Schoenfeld PS
    Am J Gastroenterol; 2005 Jan; 100(1):3-4. PubMed ID: 15654771
    [No Abstract]   [Full Text] [Related]  

  • 10. Bile acid malabsorption: an under-investigated differential diagnosis in patients presenting with diarrhea predominant irritable bowel syndrome type symptoms.
    Kurien M; Evans KE; Leeds JS; Hopper AD; Harris A; Sanders DS
    Scand J Gastroenterol; 2011 Jul; 46(7-8):818-22. PubMed ID: 21492055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. End points in irritable bowel syndrome.
    Mangel AW; Fehnel SE
    Expert Rev Gastroenterol Hepatol; 2011 Jun; 5(3):293-5. PubMed ID: 21651345
    [No Abstract]   [Full Text] [Related]  

  • 12. Safety and efficacy of tegaserod therapy in patients with irritable bowel syndrome or chronic constipation.
    Al-Judaibi B; Chande N; Gregor J
    Can J Clin Pharmacol; 2010; 17(1):e194-200. PubMed ID: 20410554
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Perhaps it is time to rethink IBS-D.
    Habba SF
    Scand J Gastroenterol; 2012 Jan; 47(1):122-3. PubMed ID: 21859399
    [No Abstract]   [Full Text] [Related]  

  • 14. Irritable bowel syndrome and diverticular disease: association or misdiagnosis?
    Tursi A
    Am J Gastroenterol; 2010 Oct; 105(10):2293; author reply 2293-4. PubMed ID: 20927068
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome.
    Sadik R; Björnsson E; Simrén M
    Eur J Gastroenterol Hepatol; 2010 Jan; 22(1):102-8. PubMed ID: 19701093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utility of symptom-based criteria for evaluating patients with chronic diarrhea.
    Pardi DS; Limsui D
    Gastrointest Endosc; 2005 Oct; 62(4):649. PubMed ID: 16185997
    [No Abstract]   [Full Text] [Related]  

  • 17. [Etiology of chronic diarrhea in the elderly in Hospital Edgardo Rebagliati, Lima-Peru].
    Arcana Lopez R; Frisancho Velarde O; Chacaltana A
    Rev Gastroenterol Peru; 2012; 32(4):366-70. PubMed ID: 23307086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The prevalence of small intestinal bacterial vergrowth in irritable bowel syndrome.
    Mann NS; Limoges-Gonzales M
    Hepatogastroenterology; 2009; 56(91-92):718-21. PubMed ID: 19621689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Importance of diarrhea in evaluating constipation in irritable bowel syndrome clinical studies.
    Basseri RJ; Kunkel D; Low K; Conklin JL; Pimentel M
    J Clin Gastroenterol; 2011 Oct; 45(9):790-3. PubMed ID: 21301356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.
    Mearin F; Badía X; Balboa A; Benavent J; Caballero AM; Domínguez-Muñoz E; Garrigues V; Piqué JM; Roset M; Cucala M; Figueras M;
    Aliment Pharmacol Ther; 2006 Mar; 23(6):815-26. PubMed ID: 16556184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.